Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
Conditions
- Cognitive Impairment
- Metastatic Malignant Neoplasm in the Brain
- Solid Neoplasm
Interventions
- RADIATION: Whole brain radiation therapy with hippocampal avoidance
- DRUG: Memantine
- RADIATION: Whole brain radiation therapy
Sponsor
NRG Oncology
Collaborators